School of Humanities & Social Sciences, Leeds Beckett University, UK.
Institute of Health and Wellbeing, University of Glasgow, UK.
Ann Behav Med. 2023 Apr 22;57(5):386-398. doi: 10.1093/abm/kaac068.
People with type 2 diabetes mellitus (T2DM) have a higher risk of developing breast and bowel cancers but are less likely to participate in cancer screening.
Two interlinked studies examined public awareness of the fact that T2DM increases breast and bowel cancer risk, and provision of this information on diabetes websites.
Study-1: phase-1 surveyed awareness of T2DM-increased cancer risk in a nationally-representative British sample aged 50-74 (N = 1,458) and compared respondents with and without T2DM (n = 125 vs. n = 1,305); phase-2 surveyed an additional exclusively T2DM sample (N = 319). Study-2: High-ranking diabetes websites (N = 25) were reviewed to determine the rate of inclusion of cancer risk and cancer screening information in evident sections about diabetes-related health conditions.
A low proportion of respondents were aware that T2DM increases risk of breast (13.7%) and bowel (27.6%) cancers, compared to much higher awareness of other diabetes-related conditions such as sight loss (82.2%) and foot problems (81.8%). Respondents with T2DM were significantly more likely than those without T2DM to be aware of all the surveyed diabetes-related health conditions (e.g., sight loss, OR: 3.14, 95%CI: 1.61-6.15; foot problems, OR: 2.58, 95%CI: 1.38-4.81), except breast (OR: 0.82, 95%CI: 0.46-1.45) and bowel (OR: 0.95, 95%CI: 0.63-1.45) cancer, for which awareness was equally low among people with and without T2DM. Few diabetes websites with a section on diabetes-related health conditions included cancer in this section (n = 4/19), and fewer still included cancer screening among any noted cancer-protective behaviors (n = 2/4).
There is low public awareness that T2DM increases the risk of developing breast and bowel cancers, even among people with T2DM, which may be partly due to limited information provision regarding T2DM-increased cancer risk from diabetes care providers and organizations.
2 型糖尿病（T2DM）患者罹患乳腺癌和肠癌的风险更高，但参与癌症筛查的可能性较低。
两项相互关联的研究调查了公众对 T2DM 增加乳腺癌和肠癌风险这一事实的认知程度，以及糖尿病网站提供相关信息的情况。
研究 1：第 1 阶段调查了在具有全国代表性的 50-74 岁英国人群中（N=1458），T2DM 增加癌症风险的认知情况，并比较了有 T2DM（n=125）和无 T2DM（n=1305）的受访者；第 2 阶段调查了额外的 T2DM 纯样本（N=319）。研究 2：对排名较高的糖尿病网站（N=25）进行了审查，以确定在关于糖尿病相关健康状况的明确部分中包含癌症风险和癌症筛查信息的比率。
与其他与糖尿病相关的疾病（如视力丧失[82.2%]和足部问题[81.8%]）相比，只有少数受访者意识到 T2DM 会增加乳腺癌（13.7%）和肠癌（27.6%）的风险。与没有 T2DM 的受访者相比，患有 T2DM 的受访者更有可能意识到所有调查的与糖尿病相关的健康状况（例如，视力丧失，OR：3.14，95%CI：1.61-6.15；足部问题，OR：2.58，95%CI：1.38-4.81），但乳腺癌（OR：0.82，95%CI：0.46-1.45）和肠癌（OR：0.95，95%CI：0.63-1.45）除外，这两种癌症的认知度在有或没有 T2DM 的人群中均较低。很少有糖尿病网站在糖尿病相关健康状况的部分中包含癌症（n=4/19），而在提到的任何癌症保护行为中，包含癌症筛查的则更少（n=2/4）。
公众对 T2DM 会增加罹患乳腺癌和肠癌风险的认识较低，即使在患有 T2DM 的人群中也是如此，这可能部分归因于糖尿病护理提供者和组织提供有关 T2DM 增加癌症风险的信息有限。
